Both the messenger substance nitrogen monoxide (NO) and the protein survivin play a role in this. The results of the study, carried out in patients with head-neck tumors, recently appeared in the International Journal of Cancer (Fetz et al., 2008).
In another publication in the journal Cancer Research (Engels et al., 2008), which appeared in the summer of this year, researchers had already reported the discovery of a similar mechanism in ovarian cancer. This raises the possibility that the "NO/survivin axis" may be a common denominator that plays a role in a large number of different types of cancer.
Every year, at least 10,000 people develop malignant cancer of the head-neck region. Despite a positive outcome after surgery, radiotherapy, and/or chemotherapy, the majority of these patients suffer a relapse after initial treatment, with the development of distant metastases being a frequent complication. The molecular causes of the development and progression of head-neck cancers and their response to treatment are still not yet adequately understood.
In the recent comprehensive study, researchers from the University Hospital of Johannes Gutenberg University Mainz were for the first time able to identify the molecular mechanism by which the messenger substance nitrogen monoxide (NO) contributes towards the growth and the resistance to treatment of head-neck cancers. NO plays a role in numerous physiological but also pathological processes: Thus, for example, most cancer cells produce increased amounts of NO and in result appear to gain a survival advantage. Until recently, it was not clear how they do this. The researchers in Mainz have now managed to demonstrate that NO or the NO-producing protein - known as iNOS in medical jargon - induces the synthesis of another protein called survivin. The name survivin is derived from the verb "to survive", which also offers a clue to its function: survivin was only recently identified by researchers as one of the central factors important with regard to the occurrence of relapses and the resistance of head-neck cancers to treatment, as it prevents the programmed death (apoptosis) of cancerous cells. (Engels et al., 2007) The increased formation of iNOS - and therefore the messenger substance NO - results in activation of certain signal pathways in the cancer cells, which ultimately leads to an increase in the production of survivin. Its properties as an inhibitor of programmed cell death are in turn exploited by the cancer cells to protect themselves against attack by chemo- or radiotherapy so that cancer cells employ, as it were, the "iNOS/survivin" axis as a survival aid.
"This new molecular understanding of the defense mechanisms of cancer cells now allows us to focus on these defensive mechanisms," reports Professor Roland Stauber, head of the Department of Molecular and Cellular Oncology. The results of tests conducted on cultured cancer cells within the framework of this study have been promising, as they have shown that the combined use of chemical iNOS inhibitors and a blockade of survivin synthesis can efficiently kill off tumor cells.
The researchers are even one step ahead: "We already managed to demonstrate earlier this year that this is a mechanism that is not simply restricted to head-neck cancers when we discovered the significance of the iNOS/survivin axis in ovarian cancer," explained Professor Stauber. "These results confirm our multidisciplinary approach, in which we conduct basic research to identify mechanisms the effects of which can then be verified in a range of tumor entities in close co-operation with various medical disciplines. This also allows us to quickly and effectively identify mechanisms that are not restricted to a specific indication. This ultimately benefits patients, as the results of the initial research benefit them sooner."
The challenge for the clinicians and researchers now lies in testing the efficacy and safety of this strategy in tumor models, thus better enabling them to assess the potential clinical benefits of the approach. "These complex investigations can, however, only be carried out with the help of national sponsors," pointed out Professor Stauber. "We therefore hope that we will continue to receive support for our indication-overlapping research strategy in the future."
Chip-based optical sensor detects cancer biomarker in urine
06.12.2019 | The Optical Society
Scientist identify new marker for insecticide resistance in malaria mosquitoes
06.12.2019 | Liverpool School of Tropical Medicine
University of Texas and MIT researchers create virtual UAVs that can predict vehicle health, enable autonomous decision-making
In the not too distant future, we can expect to see our skies filled with unmanned aerial vehicles (UAVs) delivering packages, maybe even people, from location...
With ultracold chemistry, researchers get a first look at exactly what happens during a chemical reaction
The coldest chemical reaction in the known universe took place in what appears to be a chaotic mess of lasers. The appearance deceives: Deep within that...
Abnormal scarring is a serious threat resulting in non-healing chronic wounds or fibrosis. Scars form when fibroblasts, a type of cell of connective tissue, reach wounded skin and deposit plugs of extracellular matrix. Until today, the question about the exact anatomical origin of these fibroblasts has not been answered. In order to find potential ways of influencing the scarring process, the team of Dr. Yuval Rinkevich, Group Leader for Regenerative Biology at the Institute of Lung Biology and Disease at Helmholtz Zentrum München, aimed to finally find an answer. As it was already known that all scars derive from a fibroblast lineage expressing the Engrailed-1 gene - a lineage not only present in skin, but also in fascia - the researchers intentionally tried to understand whether or not fascia might be the origin of fibroblasts.
Fibroblasts kit - ready to heal wounds
Research from a leading international expert on the health of the Great Lakes suggests that the growing intensity and scale of pollution from plastics poses serious risks to human health and will continue to have profound consequences on the ecosystem.
In an article published this month in the Journal of Waste Resources and Recycling, Gail Krantzberg, a professor in the Booth School of Engineering Practice...
03.12.2019 | Event News
15.11.2019 | Event News
15.11.2019 | Event News
06.12.2019 | Earth Sciences
06.12.2019 | Life Sciences
06.12.2019 | Information Technology